PhilipJFerroneMD
Ophthalmology • Great Neck, NYRetinal Disease
Attending, North Shore University Hosp-LI Jewish Medical Center; Assistant Professor Columbia University
Dr. Ferrone is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
600 Northern Boulevard
Suite 216
Great Neck, NY 11021Phone+1 516-466-0390Fax+1 516-829-0520- Is this information wrong?
Education & Training
Duke University HospitalResidency, Ophthalmology, 1990 - 1993
Newton-Wellesley HospitalInternship, Internal Medicine, 1989 - 1990
Harvard Medical SchoolClass of 1989
Certifications & Licensure
NC State Medical License 1992 - 2024
NY State Medical License 1997 - 2024
MI State Medical License 1993 - 2009- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2007-2014
- Newsday - Top Doctors on Long Island Castle Connolly, 2008, 2010-2014
- Top MD Consumers Checkbook
- Join now to see all
Clinical Trials
- Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema Start of enrollment: 2007 Mar 01
Publications & Presentations
PubMed
- 1 citationsOpportunity Cost of Vitreoretinal Surgeries.Ella H Leung, Shriji Patel, Rahul Reddy, Nick Boucher, Chakshu Sharma, Jill Blim, Philip J Ferrone, Paul Hahn> ;Journal of Vitreoretinal Diseases. 2023 Jun 17
- 149 citationsEfficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, ...Jeffrey S Heier, Arshad M Khanani, Carlos Quezada Ruiz, Karen Basu, Philip J Ferrone, Christopher Brittain, Marta S Figueroa, Hugh Lin, Frank G Holz, Vaibhavi Patel, T...> ;Lancet. 2022 Feb 19
- 29 citationsThe Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti-Vascular Endothelial Growth Factor Injections.Samir N Patel, Peter H Tang, Philip Storey, Jeremy D. Wolfe, Jordana G. Fein, Sumit P Shah, Eric Chen, Ashkan M. Abbey, Philip J. Ferrone, Chirag P. Shah, Michelle C. ...> ;Ophthalmology. 2021 May 18
- Join now to see all
Journal Articles
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationArshad M Khanani, Sunil S Patel, Philip J Ferrone, Pravin U Dugel, JAMA Ophthalmology
Authored Content
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
Press Mentions
Drug Choice Makes Difference for Patients with Macular Degeneration – Consumer Health NewsDecember 7th, 2022- American Academy of Ophthalmology, Nov. 12-15November 22nd, 2021
Professional Memberships
- Fellow
- Board of Directors
- LI Ophthalmological SocietyMember
- NY State Ophthalmological SocietyMember
Hospital Affiliations
Long Island Jewish Medical CenterNew Hyde Park, New York- North Shore University HospitalManhasset, New York
Syosset HospitalSyosset, New York
Lenox Hill HospitalNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
